Covered recipient · General Payments record
ROSE MARY JOYNER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,259.26
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $758.56 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $169.56 | 4 |
| Lilly USA, LLC | $167.06 | 4 |
| Neurocrine BioSciences, Inc. | $134.04 | 1 |
| SK Life Science, Inc. | $124.47 | 1 |
| E.R. Squibb & Sons, L.L.C. | $75.51 | 1 |
| ABBVIE INC. | $60.13 | 3 |
| Currax Pharmaceuticals LLC | $27.79 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.70 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107428377 | CMS |
| ABBVIE INC. | $23.57 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107428379 | CMS |
| ABBVIE INC. | $19.86 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107428381 | CMS |
| Currax Pharmaceuticals LLC | $13.89 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089524855 | CMS |
| Currax Pharmaceuticals LLC | $13.90 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089524857 | CMS |
| E.R. Squibb & Sons, L.L.C. | $75.51 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101830293 | CMS |
| Lilly USA, LLC | $17.78 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933020 | CMS |
| Lilly USA, LLC | $121.37 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933022 | CMS |
| Lilly USA, LLC | $22.53 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135883054 | CMS |
| Lilly USA, LLC | $5.38 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933024 | CMS |
| Neurocrine Biosciences, Inc. | $134.04 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150919238 | CMS |
| Novo Nordisk Inc | $11.46 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100238460 | CMS |
| Novo Nordisk Inc | $124.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100487071 | CMS |
| Novo Nordisk Inc | $16.78 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100383193 | CMS |
| Novo Nordisk Inc | $16.33 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100241888 | CMS |
| SK Life Science, Inc. | $124.47 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154125285 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.